ISRG, STE and PLSE offer exposure to AI-enabled medical devices, rising healthcare demand and potential price upside, making them stocks to watch in 2026.
Intuitive Surgical, Inc. (NASDAQ: ISRG - Get Free Report) crossed below its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $428.75 and traded as low as $420.84. Intuitive Surgical shares last traded at $420.95, with a volume of 2,213,548 shares trading hands. Key Stories Impacting
Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Intuitive Surgical's adjusted EPS surged 25% as robotic platform adoption and AI innovation fueled growth, despite rising R&D costs and a litigation settlement.
Allworth Financial LP raised its stake in shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) by 14.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,489 shares of the medical equipment provider's stock after purchasing an additional 3,682 shares during the quarter.
Intuitive Surgical delivered strong Q3 2026 results with 22% revenue growth, 84% recurring revenue, and robust system placements, reinforcing my 'Buy' rating. ISRG's updated price target is $553, reflecting a more balanced EV/EBITDA multiple amid competitive and geographic pressures, yet still offering 23% upside. Upcoming 3%-5% instrument revenue-per-procedure headwinds and China price cuts are offset by expanding benign procedure adoption and installed base leverage.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?